Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
3(75.0%)
N/A
1(25.0%)
4Total
Phase 2(3)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07571681Phase 2Not Yet Recruiting

Colchicine for Autoimmune and Subacute Thyroiditis

Role: collaborator

NCT05594186Not ApplicableCompleted

Nonsurgical Management of Cesarean Scar Niche Related Abnormal Uterine Bleeding

Role: lead

NCT04870502Phase 2Completed

Effect of Ubiquinol Supplementation on Ovulation Induction in Clomiphene Citrate Resistance

Role: lead

NCT04852510Phase 2Completed

Amelioration of Polycystic Ovary Syndrome Related Disorders by Supplementation of Thymoquinone and Metformin

Role: lead

All 4 trials loaded